stoxline Quote Chart Rank Option Currency Glossary
  
Aurinia Pharmaceuticals Inc. (AUPH)
5.095  0.045 (0.89%)    04-23 10:47
Open: 5.04
High: 5.155
Volume: 217,307
  
Pre. Close: 5.05
Low: 5.02
Market Cap: 737(M)
Technical analysis
2024-04-23 10:16:15 AM
Short term     
Mid term     
Targets 6-month :  6.31 1-year :  7.38
Resists First :  5.4 Second :  6.31
Pivot price 5.03
Supports First :  4.97 Second :  4.71
MAs MA(5) :  4.97 MA(20) :  5.04
MA(100) :  6.97 MA(250) :  8.43
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  53 D(3) :  36.8
RSI RSI(14): 46.8
52-week High :  12.43 Low :  4.71
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AUPH ] has closed below upper band by 30.6%. Bollinger Bands are 75% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 23 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.07 - 5.09 5.09 - 5.11
Low: 4.86 - 4.89 4.89 - 4.91
Close: 5 - 5.05 5.05 - 5.09
Company Description

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Headline News

Fri, 19 Apr 2024
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Movies UK

Thu, 18 Apr 2024
Aurinia Pharmaceuticals: Potential For Significant Upside By Year-End 2024 (NASDAQ:AUPH) - Seeking Alpha

Thu, 18 Apr 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 1-Year Low at $4.82 - MarketBeat

Tue, 16 Apr 2024
Aurinia Pharmaceuticals to Present at Investor Conference - TipRanks.com - TipRanks

Tue, 09 Apr 2024
Aurinia Pharma to Connect at Healthcare Investor Event - TipRanks.com - TipRanks

Sun, 07 Apr 2024
When Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven? - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 145 (M)
Shares Float 132 (M)
Held by Insiders 7.4 (%)
Held by Institutions 38.5 (%)
Shares Short 12,240 (K)
Shares Short P.Month 12,100 (K)
Stock Financials
EPS -0.55
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.63
Profit Margin -44.5 %
Operating Margin -52.8 %
Return on Assets (ttm) -10.6 %
Return on Equity (ttm) -20 %
Qtrly Rev. Growth 58.5 %
Gross Profit (p.s.) 0
Sales Per Share 1.21
EBITDA (p.s.) -0.52
Qtrly Earnings Growth 0 %
Operating Cash Flow -33 (M)
Levered Free Cash Flow -4 (M)
Stock Valuations
PE Ratio -9.45
PEG Ratio 0
Price to Book value 1.93
Price to Sales 4.2
Price to Cash Flow -22.05
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android